Literature DB >> 19160796

[Effects of berberine on expression of hepatocyte nuclear factor 4alpha and glucokinase activity in mouse primary hepatocytes].

Zhong-Qing Yan1, San-Hua Leng, Fu-Er Lu, Xiao-Hong Lu, Hui Dong, Zhi-Qiang Gao.   

Abstract

OBJECTIVE: To observe the expression of hepatocyte nuclear factor 4alpha (HNF4alpha) and the activity of key enzyme glucokinase (GK) in glucose metabolism, and further to investigate the possible mechanism of berberine in treating type 2 diabetes.
METHOD: Mouse primary hepatocytes were isolated by an improved single two-step perfusion method. The murine hepatocytes were cultured and incubated with berberine (0, 1, 3, 10, 30, 100 micromol x L(-1)) and 1 mmol x L(-1) metformin for 24 h respectively. The mRNA expression of HNF4alpha were quantified by RT-PCR and the protein expression of HNF4alpha were quantified by Western-blot. And the activity of GK were detected with enzyme kinetics method. RESULT: As compared with the negative control group, at a certain concentration range, the expression of HNF4alpha mRNA and protein and the activity of GK were promoted by berberine. Both of them reached the top at the concentration of 30 micromol x L(-1) (P<0.01). But the metformin made no difference with the negative control group on the expression of HNF4alpha and the activity of GK.
CONCLUSION: It is suggested that the effects of berberine on improving glucose metabolism can be mechanically associated with its up-regulating the HNF4a expression and inducing the activity of hepatic glucokinase.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19160796

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  6 in total

1.  Berberine retarded the growth of gastric cancer xenograft tumors by targeting hepatocyte nuclear factor 4α.

Authors:  Ling-Li Li; Ze Peng; Qian Hu; Li-Jun Xu; Xin Zou; Dong-Mei Huang; Ping Yi
Journal:  World J Gastrointest Oncol       Date:  2022-04-15

2.  Berberine Attenuated Proliferation, Invasion and Migration by Targeting the AMPK/HNF4α/WNT5A Pathway in Gastric Carcinoma.

Authors:  Qian Hu; Lingli Li; Xin Zou; Lijun Xu; Ping Yi
Journal:  Front Pharmacol       Date:  2018-10-19       Impact factor: 5.810

Review 3.  Rhizoma coptidis as a Potential Treatment Agent for Type 2 Diabetes Mellitus and the Underlying Mechanisms: A Review.

Authors:  Qian Ran; Jin Wang; Lin Wang; Hai-Rong Zeng; Xiang-Bo Yang; Qin-Wan Huang
Journal:  Front Pharmacol       Date:  2019-07-22       Impact factor: 5.810

4.  A blend of phellodendron and crape myrtle improves glucose tolerance in exercise-trained men.

Authors:  Robert E Canale; Tyler M Farney; Cameron G McCarthy; Richard J Bloomer
Journal:  Nutr Metab Insights       Date:  2011-09-13

Review 5.  The antihyperglycemic effects of Rhizoma Coptidis and mechanism of actions: a review of systematic reviews and pharmacological research.

Authors:  Hui Wang; Wei Mu; Hongcai Shang; Jia Lin; Xiang Lei
Journal:  Biomed Res Int       Date:  2014-04-10       Impact factor: 3.411

6.  Gastric cancer biomarkers; A systems biology approach.

Authors:  Mohammad Saberi Anvar; Zarrin Minuchehr; Mohsen Shahlaei; Samira Kheitan
Journal:  Biochem Biophys Rep       Date:  2018-02-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.